Trial Profile
TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms TOPIC
- 20 Jun 2016 Status changed from recruiting to discontinued.
- 20 Feb 2016 Trial design published in BMC Cancer.
- 24 Nov 2015 Planned number of patients changed from 210 to 140 as reported by ClinicalTrials.gov.